Molecular and Physiologic Mechanisms of Drug Resistance in Cancer: An Overview R.S. Kerbel Editorial Introduction Pages: 1 - 2
Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets Douglas GrossmanDario C. Altieri OriginalPaper Pages: 3 - 11
Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier Anthony RéginaMichel DemeuleRichard Béliveau OriginalPaper Pages: 13 - 25
Lineage-specific Mechanism of Drug and Radiation Resistance in Melanoma Mediated by Tyrosinase-related Protein 2 Brian J. PakWendy ChuYaacov Ben-David OriginalPaper Pages: 27 - 32
Translational Regulation as a Novel Mechanism for the Development of Cellular Drug Resistance John C. SchmitzJun LiuEdward Chu OriginalPaper Pages: 33 - 41
Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies Lori A. HazlehurstWilliam S. Dalton OriginalPaper Pages: 43 - 50
Death Receptor Ligands, in Particular TRAIL, to Overcome Drug Resistance S. de JongT. TimmerE.G.E. de Vries OriginalPaper Pages: 51 - 56
Intermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’ Ralph E. Durand OriginalPaper Pages: 57 - 61
Resistance to Rapamycin: A Novel Anticancer Drug Shile HuangPeter J. Houghton OriginalPaper Pages: 69 - 78
Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches Robert S. KerbelJoanne YuJanusz Rak OriginalPaper Pages: 79 - 86
The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance Lawrence D. MayerJennifer A. Shabbits OriginalPaper Pages: 87 - 93
Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story Catherine A. O'BrianNancy E. WardFeng Chu OriginalPaper Pages: 95 - 100
Adjuvant Treatment of Colorectal Cancer: Towards Tumor-specific Immunotherapies AJM van den EertweghA BaarsHM Pinedo OriginalPaper Pages: 101 - 108
Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance Gunnar HapkeMing-biao YinYoucef M. Rustum OriginalPaper Pages: 109 - 115
The Challenge of Pathway and Environment-mediated Drug Resistance Edward A. Sausville OriginalPaper Pages: 117 - 122
Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta Beverly A. Teicher OriginalPaper Pages: 133 - 143